Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07252232 |
| Title | Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC) (RASolute 304) |
| Acronym | RASolute 304 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Revolution Medicines, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Hartford Healthcare | NOT_YET_RECRUITING | Hartford | Connecticut | 06103 | United States | Details |
| Community Health Network | RECRUITING | Indianapolis | Indiana | 46250 | United States | Details |
| Saint Luke's Cancer Institute | RECRUITING | Kansas City | Missouri | 64111 | United States | Details |
| Taylor Cancer Research Center | RECRUITING | Maumee | Ohio | 43537 | United States | Details |
| Avera Cancer Institute | RECRUITING | Sioux Falls | South Dakota | 57105 | United States | Details |
| Virginia Cancer Specialists | NOT_YET_RECRUITING | Fairfax | Virginia | 22031 | United States | Details |
| Pan American Oncology Trials, LLC | RECRUITING | San Juan | Puerto Rico | 00909 | Puerto Rico | Details |